The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants
Authors:
- Beate RueckerBRBeate Ruecker
- Mariarosaria Lang-MuritanoMLMariarosaria Lang-Muritano
- Katharina SpanausKSKatharina Spanaus
- Maik WelzelMWMaik Welzel
- Dagmar L'ALlemandDLDagmar L'ALlemand
- Franziska Phan-HugFPFranziska Phan-Hug
- Claudia KatschnigCKClaudia Katschnig
- Daniel KonradDKDaniel Konrad
- Paul-Martin HolterhusPHPaul-Martin Holterhus
- Eugen J. SchoenleESEugen J. Schoenle
- 9 May 2015
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 84 (1) , 43-48
Abstract
Background/Aims: Primary hypoaldosteronism is a rare inborn disorder with life-threatening symptoms in newborns and infants due to an aldosterone synthase defect. Diagnosis is often difficult as the plasma aldosterone concentration (PAC) can remain within the normal range and thus lead to misinterpretation and delayed initiation of life-saving therapy. We aimed to test the eligibility of the PAC/plasma renin concentration (PRC) ratio as a tool for the diagnosis of primary hypoaldosteronism in newborns and infants. Methods: Data of 9 patients aged 15 days to 12 months at the time of diagnosis were collected. The diagnosis of primary hypoaldosteronism was based on clinical and laboratory findings over a period of 12 years in 3 different centers in Switzerland. To enable a valid comparison, the values of PAC and PRC were correlated to reference methods. Results: In 6 patients, the PAC/PRC ratio could be determined and showed constantly decreased values <1 (pmol/l)/(mU/l). In 2 patients, renin was noted as plasma renin activity (PRA). PAC/PRA ratios were also clearly decreased. The diagnosis was subsequently genetically confirmed in 8 patients. Conclusion: A PAC/PRC ratio <1 pmol/mU and a PAC/PRA ratio <28 (pmol/l)/(ng/ml × h) are reliable tools to identify primary hypoaldosteronism in newborns and infants and help to diagnose this life-threatening disease faster.Keywords
This publication has 16 references indexed in Scilit:
- Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyl oxidase deficiency type IIActa Paediatrica, 2012
- The Simultaneous Measurement of Plasma-Aldosterone- and -Renin-Concentration Allows Rapid Classification of all Disorders of the Renin-Aldosterone SystemExperimental and Clinical Endocrinology & Diabetes, 2007
- Automated Chemiluminescence-Immunoassay for Aldosterone during Dynamic Testing: Comparison to Radioimmunoassays with and without Extraction StepsClinical Chemistry, 2006
- Aldosterone synthase deficiency and related disordersMolecular and Cellular Endocrinology, 2004
- Primary HyperaldosteronismExperimental and Clinical Endocrinology & Diabetes, 2002
- Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology1The Journal of Clinical Endocrinology & Metabolism, 2000
- Homozygous Deletion of Arginine-173 in the CYP11B2 Gene in a Girl with Congenital HypoaldosteronismHormone Research in Paediatrics, 1998
- Inborn errors of aldosterone biosynthesis in humansSteroids, 1995
- HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1994
- Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal VolunteersJournal of Cardiovascular Pharmacology, 1987